DRW Securities’s Insmed INSM Stock Holding History

DRW Securities’s Portfolio INSM Stock Details INSM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-14,300	Closed	-$1.04M	–	686
2024 Q3	$1.04M	Buy	+14,300	New	+$1.06M	0.03%	273

Other funds holding INSM

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

DGM

Darwin Global Management St. Helier, Jersey $3.77B AUM 307.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

DRW Securities's INSM Position: Q1 2026 in Review

DRW Securities increased its Insmed (INSM) stake by 35% in Q1 2026, buying an estimated $147K and bringing the position to 3,698 shares worth $605K. The position accounts for 0.01% of the portfolio, ranked #531.

DRW Securities first reported a position in INSM in Q3 2017 and has held it in 3 quarters since. 669 funds tracked by Wall St. Rank hold INSM as of Q1 2026.

DRW Securities held 3,698 shares of Insmed worth $605K as of Q1 2026.
DRW Securities bought 954 Insmed shares in Q1 2026, an estimated $147K.
Insmed made up 0.01% of DRW Securities's portfolio in Q1 2026, its #531 holding.
DRW Securities first reported a position in Insmed in Q3 2017 and has held it in 3 quarters since.
669 funds tracked by Wall St. Rank held Insmed as of Q1 2026.

Based on DRW Securities's 13F filing for Q1 2026, filed 13 May 2026.